Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 2/20 | 0.32 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.30 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2772797 | 1.00 | SMN1; SMN2 (0.37) | SMN1; SMN2KMT2AHPGDHTTGAA | |
| SCHEMBL19611483 | 1.00 | SMN1; SMN2 (0.37) | SMN1; SMN2KMT2AHPGDHTTGAA | |
| SCHEMBL2316237 | 1.00 | SMN1; SMN2 (0.37) | SMN1; SMN2KMT2AHPGDHTTGAA | |
| SCHEMBL17430393 | 0.93 | KMT2A (0.33) | SMN1; SMN2KMT2APSMB8PSMB5LMNA | |
| SCHEMBL19649646 | 0.93 | KMT2A (0.47) | SMN1; SMN2KMT2AGAA | |
| SCHEMBL10077571 | 0.93 | KMT2A (0.47) | SMN1; SMN2KMT2AGAALMNA | |
| SCHEMBL905722 | 0.89 | SMN1; SMN2 (0.42) | SMN1; SMN2KMT2AHPGDHTTGAA | |
| SCHEMBL1870550 | 0.89 | SMN1; SMN2 (0.42) | SMN1; SMN2KMT2AHPGDHTTGAA | |
| SCHEMBL4960230 | 0.89 | SMN1; SMN2 (0.42) | SMN1; SMN2KMT2AHPGDHTTGAA | |
| SCHEMBL379163 | 0.89 | SMN1; SMN2 (0.42) | SMN1; SMN2KMT2AHPGDHTTGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12618834-B2 | Measurement sample preparation method, analysis method, reagent, and reagent kit | SYSMEX CORPORATION (JP) | 2026-05-05 | — | — | US | claimed |
| EP-4053556-B1 | MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT | SYSMEX CORP (JP) | 2025-05-21 | — | — | EP | claimed |
| US-20220283154-A1 | MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT | SYSMEX CORPORATION (JP) | 2022-09-08 | — | — | US | claimed |
| EP-4053556-A1 | MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT | SYSMEX CORPORATION (JP) | 2022-09-07 | — | — | EP | claimed |
| EP-3249050-B1 | ENZYME ELECTRODE AND BIOSENSOR USING THE SAME | ARKRAY INC (JP) | 2019-01-23 | — | — | EP | claimed |
| US-12618834-B2 | Measurement sample preparation method, analysis method, reagent, and reagent kit | SYSMEX CORPORATION (JP) | 2026-05-05 | — | — | US | disclosed |
| EP-4720325-A1 | L-DOPA SENSORS EMPLOYING MULTICOPPER OXIDASES | The University of North Carolina at Chapel Hill (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4720268-A1 | COPPER DEHYDROGENASES ENGINEERED FROM MULTICOPPER OXIDASES AND THEIR BIOELECTROCHEMICAL APPLICATIONS | The University of North Carolina at Chapel Hill (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4053556-B1 | MEASUREMENT SAMPLE PREPARATION METHOD, ANALYSIS METHOD, REAGENT, AND REAGENT KIT | SYSMEX CORP (JP) | 2025-05-21 | — | — | EP | disclosed |
| WO-2025038468-A2 | BIOSENSOR COMPRISING A BIOREFERENCE ELECTRODE | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2025-02-20 | — | — | WO | disclosed |
| WO-2024249628-A1 | L-DOPA SENSORS EMPLOYING MULTICOPPER OXIDASES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-12-05 | — | — | WO | disclosed |
| WO-2024249641-A1 | COPPER DEHYDROGENASES ENGINEERED FROM MULTICOPPER OXIDASES AND THEIR BIOELECTROCHEMICAL APPLICATIONS | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2024-12-05 | — | — | WO | disclosed |
| US-11293921-B2 | Direct electron transfer-type oxidoreductase-modified molecular recognition element | ARKRAY, INC. (JP) | 2022-04-05 | — | — | US | disclosed |
| US-20210155675-A1 | Mutant Cytochrome Protein and Use Thereof | ARKRAY, INC. (JP) | 2021-05-27 | — | — | US | disclosed |
| US-10927162-B2 | Mutant cytochrome protein and use thereof | ARKRAY, INC. (JP) | 2021-02-23 | — | — | US | disclosed |
| US-10563242-B2 | Enzyme electrode and biosensor using the same | ARKRAY, INC. (JP) | 2020-02-18 | — | — | US | disclosed |
| EP-3249050-B1 | ENZYME ELECTRODE AND BIOSENSOR USING THE SAME | ARKRAY INC (JP) | 2019-01-23 | — | — | EP | disclosed |
| US-20170335363-A1 | Enzyme Electrode and Biosensor Using the Same | ARKRAY, INC. (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20170335363-A1 | Enzyme Electrode and Biosensor Using the Same | ARKRAY, INC. (JP) | 2017-11-23 | — | — | US | disclosed |
| US-20070298510-A1 | Target substance-detecting element, detecting material, and detector kit | CANON KABUSHIKI KAISHA (JP) | 2007-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11293921-B2 | Direct electron transfer-type oxidoreductase-modified molecular recognition element | ETFA, PRDX3, SQOR | SMN1; SMN2 4792/4885KMT2A 2899/4885HPGD 368/4885 |
| US-20210155675-A1 | Mutant Cytochrome Protein and Use Thereof | CYC1, COX15, HSPE1 | SMN1; SMN2 3695/4885KMT2A 4072/4885HPGD 946/4885 |
| US-12618834-B2 | Measurement sample preparation method, analysis method, reagent, and reagent kit | CD63, SLC18A2, EXOSC5 | SMN1; SMN2 1211/4885KMT2A 467/4885HPGD 4849/4885 |
| US-10927162-B2 | Mutant cytochrome protein and use thereof | CYC1, COX15, HSPE1 | SMN1; SMN2 3695/4885KMT2A 4072/4885HPGD 946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.